Over-eating disorders occur when the brain is not providing the patient with a signal to feel full.
According the the Chief Scientific Officer of Tryp Therapeutics (TRYP), psilocybin therapy could be used to correct the malfunctioning neural network while helping patients work through food-related anxiety.
A recent analysis found that, on average, patients who received MDMA-assisted therapy experienced a 22 point reduction in PTSD scores, whereas daily antidepressants only reduced scores by 6 to 14 points.
One year after receiving the treatments, patients still reported benefits:
84% reported improved feelings of well-being
71% had fewer nightmares
69% had less anxiety
66% had improved sleep
Why is it so effective? MDMA reduces feelings of intense anxiety, allowing patients to open up and work through traumatic memories without fear.
Novamind (NM) is planning to acquire two Arizona-based ketamine clinics from Foundations for Change. The founder of Foundations for Change, who specializes in treating veterans and first responders, will be the Medical Director of both clinics.